PIK3CA related overgrowth syndrome: genes and variants
Explore variant evidence for PIK3CA related overgrowth syndrome across 1 analyzed protein (PIK3CA). Linked ClinVar records include 30 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to PIK3CA related overgrowth syndrome
PIK3CA: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Its p110-alpha catalytic activity generates PIP3 and activates AKT-dependent growth, survival, and metabolic signaling downstream of many receptors. Activating variants are frequent cancer drivers and, when present mosaically during development, can cause PIK3CA-related overgrowth spectrum.
30 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in PIK3CA have source records linked to PIK3CA related overgrowth syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to PIK3CA related overgrowth syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PIK3CA E545A | 545 | PIK helical | Pathogenic / likely pathogenic (★★) |
| PIK3CA Q546P | 546 | PIK helical | Pathogenic / likely pathogenic (★★) |
| PIK3CA Q546R | 546 | PIK helical | Pathogenic / likely pathogenic (★★) |
| PIK3CA D350G | 350 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA E81K | 81 | PI3K-ABD | Pathogenic / likely pathogenic (★★) |
| PIK3CA R88Q | 88 | PI3K-ABD | Pathogenic / likely pathogenic (★★) |
| PIK3CA R115P | 115 | Pathogenic / likely pathogenic (★★) | |
| PIK3CA D350N | 350 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA C378Y | 378 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA M1004I | 1004 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| PIK3CA Y1021H | 1021 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| PIK3CA M1043I | 1043 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| PIK3CA R93W | 93 | PI3K-ABD | Pathogenic / likely pathogenic (★★) |
| PIK3CA G118D | 118 | Pathogenic / likely pathogenic (★★) | |
| PIK3CA V344M | 344 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA G364R | 364 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA E365K | 365 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA E418K | 418 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA P449L | 449 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA E453K | 453 | C2 PI3K-type | Pathogenic / likely pathogenic (★★) |
| PIK3CA T1025A | 1025 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| PIK3CA E545K | 545 | PIK helical | Pathogenic / likely pathogenic (★) |
| PIK3CA E545G | 545 | PIK helical | Pathogenic / likely pathogenic (★) |
| PIK3CA Q546L | 546 | PIK helical | Pathogenic / likely pathogenic (★) |
| PIK3CA Q546E | 546 | PIK helical | Pathogenic / likely pathogenic (★) |
| PIK3CA C901F | 901 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★) |
| PIK3CA A1035V | 1035 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★) |
| PIK3CA E39K | 39 | PI3K-ABD | Pathogenic / likely pathogenic (★) |
| PIK3CA D91N | 91 | PI3K-ABD | Pathogenic / likely pathogenic |
| PIK3CA F909L | 909 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic |
Same protein, different disease
- Cowden syndrome also has ClinVar records linked to PIK3CA variants; they fall partly in the same places as the PIK3CA related overgrowth syndrome variants (23 pathogenic / likely pathogenic).
- Megalencephaly-capillary malformation-polymicrogyria syndrome also has ClinVar records linked to PIK3CA variants; they fall partly in the same places as the PIK3CA related overgrowth syndrome variants (22 pathogenic / likely pathogenic).
- Ovarian neoplasm also has ClinVar records linked to PIK3CA variants; they fall in the same places as the PIK3CA related overgrowth syndrome variants (5 pathogenic / likely pathogenic).
- PIK3CA constitutional syndrome also has ClinVar records linked to PIK3CA variants; they fall partly in the same places as the PIK3CA related overgrowth syndrome variants (4 pathogenic / likely pathogenic).
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the PIK3CA related overgrowth syndrome variants (4 pathogenic / likely pathogenic).
Diseases related to PIK3CA related overgrowth syndrome
- Noonan syndrome, also linked to PIK3CA
- Cowden syndrome, also linked to PIK3CA
- Ovarian cancer, also linked to PIK3CA
- Hereditary breast cancer, also linked to PIK3CA
- Megalencephaly-capillary malformation-polymicrogyria syndrome, also linked to PIK3CA
- Colorectal cancer, also linked to PIK3CA
- Gastric cancer, also linked to PIK3CA
- Urinary bladder cancer, also linked to PIK3CA
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, also linked to PIK3CA
- Non-small cell lung carcinoma, also linked to PIK3CA
- Colon carcinoma, also linked to PIK3CA
- Ovarian neoplasm, also linked to PIK3CA
Frequently asked questions
Which genes have records linked to PIK3CA related overgrowth syndrome?
This view contains 1 analyzed proteins: PIK3CA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 30 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 34 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center